Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
51 /100
HIGH RISK
Score updated Aug 28, 2026

MGX — Metagenomi Therapeutics, Inc. Dilution Risk Tracker

Track MGX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MGX — Get alerts when the score changes →

As of August 28, 2026, Metagenomi Therapeutics, Inc. (MGX) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Metagenomi Therapeutics, Inc. has a market capitalization of $51.20M, 37.78M shares outstanding, 51 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 33%
🔄 Reverse Split model est. 45%
• 50-day avg $1.39 approaching $1 threshold
• Only 5 months cash — financial pressure
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔔 Track MGX — Get forecast alerts →

Market Data

Market Cap$51.20M
Shares Outstanding37.78M
Float27.35M
Cash$39.03M
Debt$39.19M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 20.6% shares (2026Q1 vs prior)
51 institutional holders · 8.26M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.12M shares
#2 RENAISSANCE TECHNOLOGIES LLC 787.9K shares
#3 Catalio Capital Management, LP 529.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.49M
Days to Cover10.1
% of Float5.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track MGX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MGX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

ALLO AMSS APC APRE AVEX CAMP CERO CLRO CRIS DMRA

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MGX
MGX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.